Janus Henderson Global Life Sciences D (JNGLX)

JNGLX Holdings List

As of Aug 31, 2025

Filter results

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	8.39%	512,424
2	LON: AZN	AstraZeneca PLC	4.55%	1,278,520
3	JNJ	Johnson & Johnson	4.54%	1,146,248
4	UNH	UnitedHealth Group Incorporated	3.91%	564,809
5	ABT	Abbott Laboratories	3.23%	1,090,033
6	BSX	Boston Scientific Corporation	3.08%	1,304,366
7	ARGX	argenx SE	3.05%	191,526
8	ABBV	AbbVie Inc.	3.04%	645,913
9	EPA: SAN	Sanofi	2.97%	1,345,717
10	NVSN.MX	Novartis AG ADR	2.62%	926,611
11	TMO	Thermo Fisher Scientific Inc.	2.41%	219,051
12	AMGN	Amgen Inc.	2.40%	373,716
13	ISRG	Intuitive Surgical, Inc.	2.31%	218,320
14	VRTX	Vertex Pharmaceuticals Incorporated	2.16%	246,775
15	HCA	HCA Healthcare, Inc.	2.09%	231,088
16	SYK	Stryker Corporation	1.99%	227,857
17	DHR	Danaher Corporation	1.97%	428,571
18	BBIO	BridgeBio Pharma, Inc.	1.79%	1,545,696
19	MDT	Medtronic plc	1.78%	859,221
20	ASND	Ascendis Pharma A/S	1.68%	386,034
21	CVS	CVS Health Corporation	1.65%	1,007,840
22	RNA	Avidity Biosciences, Inc.	1.56%	1,499,084
23	SWX: ROG	Roche Holding AG	1.55%	213,540
24	MDGL	Madrigal Pharmaceuticals, Inc.	1.48%	151,065
25	AKRO	Akero Therapeutics, Inc.	1.36%	1,301,613

Showing 25 of 103 holdings

Subscribe to see the full list

Asset Allocation

Asset Class	% Weight
Stocks	98.57%
Cash	0.65%
Other	0.50%
Not Classified	0.28%

Sector Breakdown

Sector	% Weight
Health Care	92.64%
Other	7.36%

Country Breakdown

Sector	% Weight
United States	78.43%
United Kingdom	4.96%
Ireland	4.30%
Switzerland	2.75%
Denmark	2.72%
DU	2.30%
France	1.93%
Japan	1.44%
Other	0.67%
Germany	0.46%
China	0.04%